Active substance
Etodolac
- SFDA 1
- US FDA 43
- US price lines 7
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LODINE 300MG CAPS | 300 mg | Capsule, soft · Oral use | 30 Blister | SAR 62.40 | NCE · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ETODOLAC | 400MG; 500MG | tablet · oral | PANGEA | Prescription | 11 Apr 1997 |
| ETODOLAC | 400MG; 500MG | tablet · oral | TARO PHARM INDS | Prescription | 11 Mar 1998 |
| ETODOLAC | 200MG; 300MG | capsule · oral | TARO | Prescription | 30 Apr 1998 |
| ETODOLAC | 200MG; 300MG | capsule · oral | ANI PHARMS | Prescription | 16 Sep 1999 |
| ETODOLAC | 200MG; 300MG | capsule · oral | APOTEX | Prescription | 28 Jul 2000 |
| ETODOLAC | 600MG; 500MG; 400MG | tablet, extended release · oral | TEVA | Prescription | 31 Jul 2000 |
| ETODOLAC | 400MG; 500MG | tablet · oral | APOTEX | Prescription | 3 Dec 2002 |
| ETODOLAC | 400MG; 500MG; 600MG | tablet, extended release · oral | TARO | Prescription | 13 Mar 2003 |
| ETODOLAC | 400MG; 500MG; 600MG | tablet, extended release · oral | ZYDUS PHARMS | Prescription | 23 Jan 2014 |
| ETODOLAC | 400MG; 500MG | tablet · oral | AMNEAL PHARMS CO | Prescription | 7 Jun 2018 |
| ETODOLAC | 400MG; 500MG | tablet · oral | ADAPTIS | Prescription | 30 Nov 2018 |
| ETODOLAC | 400MG; 500MG; 600MG | tablet, extended release · oral | UNICHEM | Prescription | 24 Nov 2020 |
| ETODOLAC | 400MG; 500MG | tablet · oral | IPCA LABS LTD | Prescription | 1 May 2024 |
| ETODOLAC | 200MG; 300MG | capsule · oral | IPCA LABS LTD | Prescription | 1 Aug 2024 |
| ETODOLAC | 400MG; 500MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 15 Jul 2026 |
| LODINE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 300MG | capsule · oral | WYETH PHARMS INC | Discontinued | 31 Jan 1991 |
| LODINE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | WYETH PHARMS INC | Discontinued | 31 Jan 1991 |
| LODINE XL | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, extended release · oral | WYETH PHARMS INC | Discontinued | 25 Oct 1996 |
| ETODOLAC | 400MG; 500MG | tablet · oral | TP ANDA HOLDINGS | Discontinued | 28 Feb 1997 |
| ETODOLAC | 400MG | tablet · oral | SHREE HARI INTL | Discontinued | 28 Feb 1997 |
| ETODOLAC | 400MG; 500MG | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 28 Feb 1997 |
| ETODOLAC | 400MG; 500MG | tablet · oral | WATSON LABS | Discontinued | 16 Apr 1997 |
| ETODOLAC | 200MG; 300MG | capsule · oral | NATCO PHARMA | Discontinued | 16 May 1997 |
| ETODOLAC | 400MG | tablet · oral | CHARTWELL MOLECULES | Discontinued | 27 Jun 1997 |
| ETODOLAC | 200MG; 300MG | capsule · oral | ANI PHARMS | Discontinued | 8 Jul 1997 |
18 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ETODOLAC 200 MG CAPSULE | $0.29637 | per EA | 23 Sep 2026 |
| US NADAC | ETODOLAC 300 MG CAPSULE | $0.41563 | per EA | 23 Sep 2026 |
| US NADAC | ETODOLAC 400 MG TABLET | $0.26236 | per EA | 23 Sep 2026 |
| US NADAC | ETODOLAC 500 MG TABLET | $0.28517 | per EA | 23 Sep 2026 |
| US NADAC | ETODOLAC ER 400 MG TABLET | $0.61584 | per EA | 23 Sep 2026 |
| US NADAC | ETODOLAC ER 500 MG TABLET | $0.71762 | per EA | 23 Sep 2026 |
| US NADAC | ETODOLAC ER 600 MG TABLET | $1.07277 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Etodolac 600mg modified-release tablets | £18.58 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.